Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bitzer

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
Cancer Research|September 23, 2010
Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virusMichael D Mühlebach, Thomas Schaser, Martina Zimmermann, et al.
Plos One|March 7, 2014
Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumorsMartina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2023
Sabrina Groß, Michael Bitzer, Susanne Blödt, et al.
Pediatric Surgery International|December 24, 2005
In vitro gene targeting in human hepatoblastomaSteven W Warmann, Sorin Armeanu, Heike Frank, et al.
Frontiers in Oncology|September 10, 2014
Epigenetic impacts of ascorbate on human metastatic melanoma cellsSascha Venturelli, Tobias W Sinnberg, Alexander Berger, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 22, 2012
Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro studyAdrian Lupescu, Nazneen Shaik, Kashif Jilani, et al.
Pediatric Blood & Cancer|February 13, 2009
Adenovirus-mediated cytosine deaminase/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitroSteven W Warmann, Sorin Armeanu, Heike Heigoldt, et al.
Plos One|June 18, 2021
COVID-19 in persons aged 70+ in an early affected German district: Risk factors, mortality and post-COVID care needs-A retrospective observational study of hospitalized and non-hospitalized patientsMatthias L Herrmann, Johannes-Martin Hahn, Birgit Walter-Frank, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2014
TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trialAndreas Erhardt, Frank Kolligs, Matthias Dollinger, et al.
NPJ Precision Oncology|February 25, 2026
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsiesAaron Stahl, Karsten Büringer, Pavlos Missios, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Cancer Research|September 23, 2010
Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virusMichael D Mühlebach, Thomas Schaser, Martina Zimmermann, et al.
Plos One|March 7, 2014
Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumorsMartina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2023
Sabrina Groß, Michael Bitzer, Susanne Blödt, et al.
Pediatric Surgery International|December 24, 2005
In vitro gene targeting in human hepatoblastomaSteven W Warmann, Sorin Armeanu, Heike Frank, et al.
Frontiers in Oncology|September 10, 2014
Epigenetic impacts of ascorbate on human metastatic melanoma cellsSascha Venturelli, Tobias W Sinnberg, Alexander Berger, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 22, 2012
Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro studyAdrian Lupescu, Nazneen Shaik, Kashif Jilani, et al.
Pediatric Blood & Cancer|February 13, 2009
Adenovirus-mediated cytosine deaminase/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitroSteven W Warmann, Sorin Armeanu, Heike Heigoldt, et al.
Plos One|June 18, 2021
COVID-19 in persons aged 70+ in an early affected German district: Risk factors, mortality and post-COVID care needs-A retrospective observational study of hospitalized and non-hospitalized patientsMatthias L Herrmann, Johannes-Martin Hahn, Birgit Walter-Frank, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2014
TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trialAndreas Erhardt, Frank Kolligs, Matthias Dollinger, et al.
NPJ Precision Oncology|February 25, 2026
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsiesAaron Stahl, Karsten Büringer, Pavlos Missios, et al.
Pageof 19